P-Tax 260 Injection
Marketer
Symbion Lifescience
Salt Composition
Paclitaxel (6mg)
Overview P-Tax 260 Injection
Taxotene 260 Injection, an antineoplastic agent, treats breast, pancreatic, and non-small-cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include nausea, vomiting, and fatigue; serious side effects may encompass edema (hands, lips), alopecia, and weight increase. Concomitant medications may mitigate side effects. Report unusual bruising, bleeding, pharyngitis, oral ulcers, or fever immediately. This medication can reduce blood cell counts (red and white), increasing infection risk; regular blood tests monitor blood cell levels and liver function. Inform your doctor of pre-existing heart, liver, or kidney disease, or any concurrent antimicrobial therapy before commencing treatment. Interactions with other drugs are possible; disclose all medications. Use during pregnancy or breastfeeding is contraindicated; effective contraception is essential for both partners throughout the treatment period.
Primary Ingredients of P-Tax 260 Injection
No text provided to rephrase.
Uses of P-Tax 260 Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of P-Tax 260 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of P-Tax 260 Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use P-Tax 260 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How P-Tax 260 Injection works:
Taxotere 260 Injection is a chemotherapy agent used in cancer treatment. Its mechanism of action involves disruption of microtubules, essential components for cancer cell division and proliferation. This disruption inhibits cancer cell growth, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Combining P-Tax 260 Injection and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering P-Tax 260 Injection during pregnancy poses a confirmed risk to the fetus and is therefore contraindicated. Nevertheless, in exceptional circumstances involving a life-threatening condition, a physician might deem its use justifiable if the potential advantages outweigh the inherent dangers. Seek medical advice before using this medication.
Breast feedingUNSAFE
Administering P-Tax 260 Injection while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingUNSAFE
Administering P-Tax 260 Injection may induce adverse reactions impacting driving capabilities. While continued driving between treatment cycles isn't inherently prohibited, the injection's alcohol content suggests caution regarding driving is warranted.
KidneySAFE IF PRESCRIBED
P-Tax 260 Injection poses no safety concerns for individuals with kidney impairment; dosage modification is unnecessary. Nevertheless, patients with pre-existing kidney conditions should consult their physician.
LiverCAUTION
Individuals with hepatic impairment should use P-Tax 260 Injection cautiously, potentially requiring dosage modification. Consult a physician for guidance. P-Tax 260 Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take P-Tax 260 Injection :
NA
Facts to Know About P-Tax 260 Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane-Based Drugs |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently